COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition

التفاصيل البيبلوغرافية
العنوان: COVID-19 in lymphangioleiomyomatosis: an international study of outcomes and impact of mTOR inhibition
المؤلفون: Bruno Guedes, Baldi, Elzbieta, Radzikowska, Vincent, Cottin, Daniel F, Dilling, Ali, Ataya, Carlos Roberto Ribeiro, Carvalho, Sergio, Harari, Matthew, Koslow, Jan C, Grutters, Yoshikazu, Inoue, Nishant, Gupta, Simon R, Johnson
المصدر: Chest
بيانات النشر: American College of Chest Physicians. Published by Elsevier Inc., 2021.
سنة النشر: 2021
مصطلحات موضوعية: RT-PCR, reverse-transcription polymerase chain reaction, Lung Neoplasms, DLCO, diffusing capacity of the lungs for carbon monoxide, Tumor Suppressor Proteins, Settore MED/10 - Malattie dell'Apparato Respiratorio, BMI, body mass index, mTOR, mechanistic target of rapamycin, COVID-19, LAM, patient outcome assessment, FEV1, forced expiratory volume in the first second, Hospitalization, LAM, lymphangioleiomyomatosis, sirolimus, Tuberous Sclerosis Complex 2 Protein, FVC, forced vital capacity, Research Letter, UK, United Kingdom, Humans, Lymphangioleiomyomatosis, TSC, tuberous sclerosis complex, USA, United States of America, COVID-19, coronavirus disease 19, TSC
اللغة: English
تدمد: 1931-3543
0012-3692
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c55f307972bcb17e62cdac299d737befTest
http://europepmc.org/articles/PMC8687712Test
حقوق: OPEN
رقم الانضمام: edsair.pmid.dedup....c55f307972bcb17e62cdac299d737bef
قاعدة البيانات: OpenAIRE